Citigroup’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.9K | Buy |
31,814
+1,848
| +6% | +$4.58K | ﹤0.01% | 3803 |
|
|
2025
Q1 | $46.4K | Sell |
29,966
-1,503
| -5% | -$2.33K | ﹤0.01% | 4115 |
|
|
2024
Q4 | $67.3K | Buy |
31,469
+2,664
| +9% | +$5.7K | ﹤0.01% | 4152 |
|
|
2024
Q3 | $125K | Buy |
28,805
+20,642
| +253% | +$89.8K | ﹤0.01% | 3884 |
|
|
2024
Q2 | $38K | Sell |
8,163
-104,288
| -93% | -$486K | ﹤0.01% | 4003 |
|
|
2024
Q1 | $570K | Buy |
112,451
+58,327
| +108% | +$296K | ﹤0.01% | 2763 |
|
|
2023
Q4 | $152K | Sell |
54,124
-7,224
| -12% | -$20.3K | ﹤0.01% | 3305 |
|
|
2023
Q3 | $176K | Buy |
+61,348
| New | +$176K | ﹤0.01% | 3039 |
|
|
2023
Q1 | – | Sell |
-135
| Closed | -$243 | – | 4743 |
|
|
2022
Q4 | $243 | Sell |
135
-438
| -76% | -$788 | ﹤0.01% | 4779 |
|
|
2022
Q3 | $1K | Sell |
573
-481
| -46% | -$839 | ﹤0.01% | 4774 |
|
|
2022
Q2 | $3K | Sell |
1,054
-908
| -46% | -$2.58K | ﹤0.01% | 4969 |
|
|
2022
Q1 | $5K | Sell |
1,962
-4,934
| -72% | -$12.6K | ﹤0.01% | 4978 |
|
|
2021
Q4 | $37K | Sell |
6,896
-42,002
| -86% | -$225K | ﹤0.01% | 4433 |
|
|
2021
Q3 | $414K | Sell |
48,898
-7,302
| -13% | -$61.8K | ﹤0.01% | 3016 |
|
|
2021
Q2 | $685K | Sell |
56,200
-71,691
| -56% | -$874K | ﹤0.01% | 2858 |
|
|
2021
Q1 | $3.1M | Buy |
127,891
+120,421
| +1,612% | +$2.92M | ﹤0.01% | 1659 |
|
|
2020
Q4 | $239K | Buy |
7,470
+4,614
| +162% | +$148K | ﹤0.01% | 3134 |
|
|
2020
Q3 | $86K | Sell |
2,856
-1,133
| -28% | -$34.1K | ﹤0.01% | 3212 |
|
|
2020
Q2 | $169K | Buy |
3,989
+452
| +13% | +$19.2K | ﹤0.01% | 3168 |
|
|
2020
Q1 | $88K | Buy |
+3,537
| New | +$88K | ﹤0.01% | 3372 |
|